Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): Study protocol for a randomized controlled trial
- Yardley, D.A.
- Brufsky, A.
- Coleman, R.E.
- Conte, P.F.
- Cortes, J.
- Glück, S.
- Nabholtz, J.-M.A.
- O'Shaughnessy, J.
- Beck, R.M.
- Ko, A.
- Renschler, M.F.
- Barton, D.
- Harbeck, N.
Aldizkaria:
Trials
ISSN: 1745-6215
Argitalpen urtea: 2015
Alea: 16
Zenbakia: 1
Mota: Artikulua